Denmark-based AI software developer Radiobotics has announced that Peter Ulvskjold has become its CEO, with effect from 1 October.
Ulvskjold has more than 20 years of pharma and medtech experience, working internationally in general management, commercialization, strategic execution, and globalization in various senior management roles at Novo Nordisk, ConvaTec, and most recently as CEO for the Swedish biotech company Atlas Antibodies, Radiobotics said.
